SMTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SMTI is not a good buy right now. Despite solid revenue growth and upbeat 2026 revenue guidance, the stock is still in a bearish technical trend (SMA_200 > SMA_20 > SMA_5) with negative MACD, and there are no Intellectia proprietary buy signals today to justify chasing the current pop. For an impatient investor looking to buy immediately, the risk/reward is not favorable until price proves strength above near-term resistance (~23.52) and trend improves.
Trend/Structure: Bearish trend remains intact with moving averages stacked bearishly (SMA_200 > SMA_20 > SMA_5), signaling the larger downtrend is still in control. Momentum: MACD histogram is negative (-0.233) but negatively contracting, which can indicate downside momentum is fading; however it is not yet a reversal confirmation. RSI: RSI(6) at ~32.3 is near the oversold boundary and suggests a potential short-term bounce risk for shorts, but it is not a clean buy signal by itself. Levels: Pivot ~21.98 (price ~22 is sitting right around it). Immediate resistance R1 ~23.52 then R2 ~24.47. Support S1 ~20.45 then S2 ~19.50. Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
FY2025 net revenue projected $102.7M-$103.2M (+19% YoY). FY2026 net revenue projected $116M-$121M (+13% to +17% vs FY2025 midpoint), supporting a growth narrative.
Technical headwind: Stock remains in a defined bearish moving-average structure, and MACD is still below zero.
Profitability/earnings quality: Latest quarter shows a very large net loss (net income at -$30.4M; EPS -3.52), which can keep pressure on sentiment even with revenue growth.
Sentiment/positioning: Hedge funds and insiders show neutral activity (no reinforcing accumulation signal).
No noted politician/congress activity to provide an additional sentiment tailwind (and no congress data available).
Latest reported quarter: 2025/Q3. Revenue rose to ~$26.33M (+21.51% YoY), showing strong top-line growth. Margins: Gross margin reported at ~90.56% (+3.39% YoY), indicating strong product-level profitability. Bottom line: Net income was -$30.41M (loss) and EPS -3.52; losses remain substantial relative to revenue, so the market may continue to demand clearer operating leverage. Forward growth: Management’s revenue outlook points to continued growth into FY2026 (mid-teens), which is supportive, but profitability execution is still the key question.
Recent trend: On 2025-11-14, H.C. Wainwright lowered the price target to $36 from $54 while reiterating a Buy after the Q3 report. Interpretation: Wall Street ‘pro’ view is that SMTI can execute a commercial plan, improve operational efficiency, and grow revenue sustainably; the maintained Buy and $36 target suggests meaningful upside from ~$22. ‘Con’ view: The price target cut signals reduced confidence or higher perceived risk/longer timeline; combined with large ongoing losses, the stock can remain technically weak until execution improves. Influential/insider/political activity check: Insiders neutral (no significant recent trend). No recent congress trading data available.
